Sec. 745. REQUIREMENT TO REVIEW AND MONITOR PRESCRIBING PRACTICES AT MILITARY TREATMENT FACILITIES OF PHARMACEUTICAL AGENTS FOR TREATMENT OF POST-TRAUMATIC STRESS
161 words·~1 min read·
/statute-compilations/comps-13740/sec-745A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 745 REQUIREMENT TO REVIEW AND MONITOR PRESCRIBING PRACTICES AT MILITARY TREATMENT FACILITIES OF PHARMACEUTICAL AGENTS FOR TREATMENT OF POST-TRAUMATIC STRESS **[**[10 U.S.C. 1074 note](/us/usc/t10/s1074)**]** ###
(a)In General Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense shall— ####
(1)conduct a comprehensive review of the prescribing practices at military treatment facilities of pharmaceutical agents for the treatment of post-traumatic stress; ####
(2)implement a process or processes to monitor the prescribing practices at military treatment facilities of pharmaceutical agents that are discouraged from use under the VA/DOD Clinical Practice Guideline for Management of Post-Traumatic Stress; and ####
(3)implement a plan to address any deviations from such guideline in prescribing practices of pharmaceutical agents for management of post-traumatic stress at such facilities. ###
(b)Pharmaceutical Agent Defined In this section, the term “pharmaceutical agent” has the meaning given that term in section 1074g(g) of title 10, United States Code.
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 745
REQUIREMENT TO REVIEW AND MONITOR PRESCRIBING PRACTICES AT MILITARY TREATMENT FACILITIES OF PHARMACEUTICAL AGENTS FOR TREATMENT OF POST-TRAUMATIC STRESS
Cites 1Cited by 0 across 0 sources